Monday, January 11, 2016

Shire to Buy Baxalta for $32 Billion

Dublin-based pharmaceutical company Shire PLC agreed to buy Baxalta Inc. in a deal that values the maker of cancer drugs at $32 billion.

from WSJ.com: US Business http://ift.tt/1PnupPb
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)